The SREBF2 gene and INSIG2 may be candidate genes for risperidone-induced dyslipidemia, obesity, and cardiovascular diseases in psychotic disorder patients. This evidence concerns the gene INSIG2 and obesity due to melanocortin 4 receptor deficiency.